Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Paul Butzler is active.

Publication


Featured researches published by Jean-Paul Butzler.


The Lancet | 1984

ACQUIRED IMMUNODEFICIENCY SYNDROME IN RWANDA

Philippe Van de Perre; Philippe Lepage; Philippe Kestelyn; AntonC. Hekker; Dominique Rouvroy; Jos Bogaerts; Joseph Kayihigi; Jean-Paul Butzler; Nathan Clumeck

To evaluate acquired immunodeficiency syndrome (AIDS) in central Africa a prospective study was done in Kigali, Rwanda, where Kaposis sarcoma (KS) is endemic. During a 4 week period, 26 patients (17 males and 9 females) were diagnosed. 16 patients had opportunistic infections, associated with KS in only 2; 1 had multifocal KS alone; and 9 had clinical conditions consistent with prodromes of AIDS. All patients had severe T-cell defects characterised by cutaneous anergy, a striking decrease in the number of helper T cells, and a decreased OKT4:OKT8 ratio (mean 0.27). 21 of the 22 adult patients were living in urban centres and many of them were in the middle to upper income bracket. Most of the men were promiscuous heterosexuals and 43% of the females were prostitutes. No patient had a history of homosexuality, intravenous drug abuse, or transfusion in the previous 5 years. This study suggests that AIDS is present in central Africa as an entity probably unrelated to the well-known endemic African KS. An association of an urban environment, a relatively high income, and heterosexual promiscuity could be a risk factor for AIDS in Africa.


Emerging Infectious Diseases | 2004

Arcobacter species in humans.

Olivier Vandenberg; Anne Dediste; Kurt Houf; Sandra Ibekwem; Hichem Souayah; Samy Cadranel; Nicole Douat; Georges Zissis; Jean-Paul Butzler; Peter Vandamme

During an 8-year study period, Arcobacter butzleri was the fourth most common Campylobacter-like organism isolated from 67,599 stool specimens. Our observations suggest that A. butzleri displays microbiologic and clinical features similar to those of Campylobacter jejuni; however, A. butzleri is more frequently associated with a persistent, watery diarrhea.


The Journal of Pediatrics | 1973

Related vibrio in stools

Jean-Paul Butzler; Paul Dekeyser; M. Detrain; Freddy Dehaen

Summary By means of a filtration technique for coproculture, it is relatively easy to isolate related vibrios from stool samples, using a medium containing antibiotics. From stools of 800 children and 100 adults presenting with diarrhea, related vibrios were isolated in 52 specimens from 41 children and 4 adults. A systematic search for vibrio in the stools of 1,000 children without diarrhea revealed 13 carriers.


The Lancet | 1985

Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III.

Philippe Van de Perre; Michel Caraël; Marjorie Robert-Guroff; Nathan Clumeck; Elie Nzabihimana; Patrick De Mol; Pierre Freyens; Robert C. Gallo; Jean-Paul Butzler; Jean-Baptiste Kanyamupira

In July, 1984 33 female prostitutes in Rwanda and 25 male customers of prostitutes were assessed clinically and for their T-lymphocyte subsets and frequency of antibodies to human T-cell lymphotropic virus type III (HTLV-III). 27 healthy males who denied contact with prostitutes, 33 healthy women who were not prostitutes, and 51 Rwandese prostitutes seen in 1983 served as controls. Only 6 prostitutes were symptom-free (group I), 13 had unexplained generalised lymphadenopathy (LAP) (group II), and 14 had LAP and constitutional symptoms (group III). Mean OKT4/OKT8 ratio in groups II and III was significantly lower than that in group I or in female controls. HTLV-III antibodies were detected in 29 of 33 prostitutes, 4 female controls, 7 male customers, and 2 male controls. In male customers, HTLV-III seropositivity increased according to the number of different sexual partners per year. This study suggests that in Central Africa prostitutes are a high-risk group for HTLV-III infection.


The Lancet | 1987

Postnatal transmission of HIV from mother to child

Philippe Lepage; Philippe Van de Perre; Michel Caraël; Nsengumuremyi F; Jean Nkurunziza; Jean-Paul Butzler; Suzanne Sprecher

2 cases of post-partum transmission of human immunodefficiency virus (HIV) from mother to infant from Kigali Rwanda are reported. All results were confirmed by western blot tests. 1) A 23-year-old woman with no history of extramarital sexual contact blood transfusions drug abuse or injections during pregnancy experienced severe bleeding during childbirth and was transfused with 2 units blood one of which had been drawn from a donor who later proved to be seropositive. The child sickened and died at 19 months of chronic diarrhea after having presented with failure to thrive generalized lymphadenopathy oral thrush and hepatomegaly moderate psychomotor delay and lobar pneumonia on chest x-ray. At 15 months post-partum the mother showed mild lymphocytosis and had antibodies to HIV. She had no dermatitis and breast-fed the child without problems until she died. 2) The 2nd case of a boy was quite similar: a postpartum transfusion from a donor who later prove to be seropositive was the most likely source of the mothers HIV infection. The child in question was still being breast fed at 15 months having begun to show symptoms of HIV infection at 5 months of age. A 30-month-old sibling was thriving and seronegative. In both cases the fathers were seronegative. Given the length of time the children had been breast fed and past studies showing the presence of HIV in breast milk as well as colostrum breast milk appears to be the most likely source of the infection in these cases. They were 2 cases out of 107 pediatric cases of AIDS and AIDS-related complex studied over 2 years. The results do not indicate a need to discourage mothers from breastfeeding but do underline the need to enforce measures to avoid contamination of banked breast milk.


Journal of Parenteral and Enteral Nutrition | 1989

Contaminated enteral nutrition solutions as a cause of nosocomial bloodstream infection: a study using plasmid fingerprinting.

Jack Levy; Yves Van Laethem; Godelieve Verhaegen; Chantal Perpête; Jean-Paul Butzler; Richard P. Wenzel

In July 1984, two patients fed enteral nutrition solutions contaminated with Enterobacter cloacae developed nosocomial bacteremia. Despite careful review of the preparation procedures as well as repeated microbiological surveys, 83 (27%) of the 309 formula bottles tested over a 1-yr period were contaminated and the source of contamination remained unknown. E. cloacae was the most frequent organism isolated (34%). The plasmid profiles of E. cloacae recovered from enteral nutrition solutions remained identical for several months. Blood culture isolates from 10 of the 40 patients who had developed E. cloacae nosocomial sepsis over a 7-yr period (1979-1985) had plasmid profiles linking them to contaminated enteral nutrition solutions. Epidemiological data from a case control study revealed that these 10 patients were indeed more likely to be exposed to enteral nutrition than the 30 others: 9/10 vs 10/30 (odds ratio 18, p = 0.002). Similarly, two of seven nosocomial Klebsiella pneumoniae bacteremias over a 6-month period in 1986 could be ascribed to administration of contaminated enteral liquid feeds prompting a general policy for using sterile commercially prepared solutions. Our results suggest that contaminated enteral nutrition solutions represent a significant cause of nosocomial sepsis.


Antimicrobial Agents and Chemotherapy | 1978

Susceptibility of Campylobacter fetus subsp. jejuni to Twenty-Nine Antimicrobial Agents

Raymond Vanhoof; M P Vanderlinden; R. Dierickx; Sabine Lauwers; Eugène Yourassowsky; Jean-Paul Butzler

The activity of 29 antimicrobial agents was tested against 95 strains of Campylobacter fetus subsp. jejuni isolated from human stools. Furazolidone and gentamycin were the most active agents. The tetracyclines, erythromycin, and chloramphenicol were very active against most of the strains, but with each antibiotic a few resistant strains were found. The penicillins were relatively inactive, and the cephalosporins tested were only active against occasional strains.


The Lancet | 1987

COMMUNITY-ACQUIRED BACTERAEMIA IN AFRICAN CHILDREN

Philippe Lepage; Jos Bogaerts; Christiaan Van Goethem; Mélanie Ntahorutaba; François Nsengumuremyi; D.G. Hitimana; Jean-Paul Butzler; J. Vandepitte; Jack Levy

To examine the frequency of community acquired bacteraemia in children in Kigali, Rwanda, blood cultures were obtained from 900 consecutive febrile children (T degrees greater than or equal to 39 degrees C) seen at an outpatient clinic over the course of a year. A pathogen was isolated from 112 children (12.4%): Salmonella typhi from 47, S enteritidis from 23, S typhimurium from 13, Streptococcus pneumoniae from 14, Staphylococcus aureus from 9, and Haemophilus influenzae from 3. Salmonella species represented 74% of the isolates. The children with S typhi bacteraemia were older (mean age 75 months) than those with bacteraemia due to other organisms. Controls consisted of febrile, nonbacteraemic children without (group I) or with (group II) Plasmodium falciparum parasitaemia. Bacteraemic children were older and presented more frequently with diarrhoea, vomiting, and dehydration, but less frequently with convulsions than controls. The rate of hospital admission was higher among bacteraemic children (61%) than among group I (39%) or group II (46%) controls. The case-fatality rate was similar in the three groups (9.3% versus 2.9% and 7.3%). Community-acquired bacteraemia in Rwandese children is common and is mainly caused by Salmonella species.


Antimicrobial Agents and Chemotherapy | 1985

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Herman Goossens; P De Mol; H. Coignau; Jack Levy; O. Grados; G. Ghysels; H Innocent; Jean-Paul Butzler

The in vitro activity of drugs currently used in the treatment of diarrhea against 595 enteropathogens from worldwide sources was compared with that of six newly developed antibiotics, ciprofloxacin; norfloxacin; ofloxacin; aztreonam; HR810, an expanded-spectrum cephalosporin; and RU28965, a new macrolide. In contrast with ampicillin and chloramphenicol, trimethoprim-sulfamethoxazole showed an excellent activity against all of the enteropathogens tested, except Campylobacter species. Ciprofloxacin had the highest activity, with an overall 90% MIC of less than or equal to 0.097 micrograms/ml, except for Campylobacter species (0.39 micrograms/ml). Unlike other cephalosporins, HR810 showed a satisfactory activity against Campylobacter species (90% MIC of 3.12 micrograms/ml). RU28965 was three times less active than erythromycin against Campylobacter species.


Scandinavian Journal of Infectious Diseases | 1988

Herpes zoster in African patients: an early manifestation of HIV infection.

Philippe Van de Perre; Eric Bakkers; Jean Batungwanayo; Philippe Kestelyn; Philippe Lepage; Didace Nzaramba; Jos Bogaerts; Antoine Serufilira; Dominique Rouvroy; Alphonse Uwimana; Jean-Paul Butzler

During a 3-month period, 131 cases of herpes zoster were diagnosed in Kigali, Rwanda. There were 46 female and 85 male patients. Mean age was 29 years (range 1-66). An unusually high proportion of patients presented with cranial and sacral nerve localisation of their cutaneous lesions. 55/131 patients (42%) had involvement of more than one dermatome. None of the patients had an underlying condition known to favour herpes zoster. 120/131 (92%) had antibodies to HIV detected by an immunoenzymatic assay (EIA) and indirect immunofluorescence. 92/125 adult patients (74%) had no sign or symptom related to HIV infection other than herpes zoster. This study suggests that herpes zoster in Central Africa is an early and readily detectable manifestation of HIV-induced immunosuppression.

Collaboration


Dive into the Jean-Paul Butzler's collaboration.

Top Co-Authors

Avatar

Olivier Vandenberg

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L Vlaes

Free University of Brussels

View shared research outputs
Top Co-Authors

Avatar

Nathan Clumeck

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Jack Levy

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. De Mol

Free University of Brussels

View shared research outputs
Top Co-Authors

Avatar

Patricia Retore

Free University of Brussels

View shared research outputs
Researchain Logo
Decentralizing Knowledge